spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Clinical Trial Supply West Coast 2018

23-24 May 2018
Burlingame, CA

Clinical Trial Supply West Coast is returning for its 11th edition to share strategies for improving the efficiency of their clinical supply chain operations. The programme covers a broad range of topics including GMP compliance, transport management software, change control, machine learning, QP release and overcoming customs delays.

The 2018 programme offers delegates a dynamic programme of case-study presentations, interactive panel discussions and workshops and networking breaks which will enable the audience to take away practical strategies that can be used to improve the efficiency of their clinical supply chains.

2018 Agenda Highlights:

  • Interactive panel: Debating the efficiencies of comparator and placebo controlled trials
  • Uncovering border control requirements to ensure your trial drug reaches their destination without delays 
  • Using and advancing the use of Artificial Intelligence(AI) as a tool facilitating clinical trial operations and improve efficiency in clinical supply 
  • Assessing the use of IVRS systems for small pharma companies as an integrated platform facilitating communication and streamlining projects 
  • Maintaining the temperature of increasing large molecule and protein-based therapies market in the Bay area to avoid product loss and the consequent costs incurred


2018 Key Speakers:

  • Karen Paese, Director, Clinical Supply Chain Management, Gilead Sciences
  • Richard Horn, Director, Clinical Supplies, Nektar Therapeutics
  • Robert Bottome, Executive Director, Global Supply Chain, BioMarin Pharmaceuticals
  • William Goure, Chief Operating Officer, Acumen
  • Louie Burks, Clinical Supply Manager, Exelixis
  • John Simons, Director of Clinical Quality Assurance, Gilead Sciences

For more information, please visit: http://www.arena-international.com/ctswest?clearcache=1or alternatively email us at: events@arena-international.com

 
Print this page
Send to a friend
   
spacer
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>


White Papers

Backward Thinking: The Reverse Engineering of A Pressurized Metered Dose Inhaler

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market. Significant information about the reference marketed product can be obtained from a thorough review of published literature, specifically the Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL). Additionally, baselining the reference marketed product for pharmaceutical performance offers a working target specification for in-vitro correlation. It will ensure the smoothest possible path to commercialization and maximize return on investment. In addition, baselining of the reference marketed product is done to understand batch-to-batch variability and product performance over the stated shelf life to establish targets for critical quality attributes (CQAs), which can be applied to the generic equivalent pMDI.
More info >>


News and Press Releases

CPhI MEA expert:growing domestic manufacturing is creating new opportunities for international Pharma in the Middle East

Abu Dhabi, 5th August 2019: CPhI Middle East expert Emad Shabbir, Director at EMAD Trade House, states favorable conditions and legislative regulations in Saudi Arabia are resulting in a boom of manufacturers and CMOs partnerships with international pharma companies. With the strategic cooperation between regional generic companies and multinational pharma companies, driving increased local production.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement